These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 2591466)

  • 21. Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
    Mogensen PH; Jórgensen L; Boas J; Dam M; Vesterager A; Flesch G; Jensen PK
    Acta Neurol Scand; 1992 Jan; 85(1):14-7. PubMed ID: 1546529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.
    Elger C; Bialer M; Falcão A; Vaz-da-Silva M; Nunes T; Almeida L; Soares-da-Silva P
    Epilepsia; 2013 Aug; 54(8):1453-61. PubMed ID: 23758485
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxcarbazepine final market image tablet formulation bioequivalence study after single administration and at steady state in healthy subjects.
    Flesch G; Tudor D; Souppart C; D'Souza J; Hossain M
    Int J Clin Pharmacol Ther; 2002 Nov; 40(11):524-32. PubMed ID: 12698990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Population pharmacokinetics of oxcarbazepine and its metabolite 10-hydroxycarbazepine in healthy subjects.
    Antunes NJ; van Dijkman SC; Lanchote VL; Wichert-Ana L; Coelho EB; Alexandre Junior V; Takayanagui OM; Tozatto E; van Hasselt JGC; Della Pasqua O
    Eur J Pharm Sci; 2017 Nov; 109S():S116-S123. PubMed ID: 28528287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereoselective pharmacokinetic analysis of the antiepileptic 10-hydroxycarbazepine in dogs.
    Volosov A; Sintov A; Bialer M
    Ther Drug Monit; 1999 Apr; 21(2):219-23. PubMed ID: 10217343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxcarbazepine disposition: preliminary observations in patients.
    Kumps A; Wurth C
    Biopharm Drug Dispos; 1990; 11(4):365-70. PubMed ID: 2340349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of charcoal on the absorption and elimination of the antiepileptic drugs lamotrigine and oxcarbazepine.
    Keränen T; Sorri A; Moilanen E; Ylitalo P
    Arzneimittelforschung; 2010; 60(7):421-6. PubMed ID: 20712131
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety, tolerability and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic agent, during first administration to humans.
    Almeida L; Soares-da-Silva P
    Drugs R D; 2003; 4(5):269-84. PubMed ID: 12952496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Further clinical and pharmacokinetic observations on the new anticonvulsant, oxcarbazepine.
    Dickinson RG; Hooper WD; Pendlebury SC; Moses D; Eadie MJ
    Clin Exp Neurol; 1988; 25():127-33. PubMed ID: 3077098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of 10-OH-carbazepine, the main metabolite of the antiepileptic oxcarbazepine, from serum and saliva concentrations.
    Kristensen O; Klitgaard NA; Jönsson B; Sindrup S
    Acta Neurol Scand; 1983 Sep; 68(3):145-50. PubMed ID: 6650125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug monitoring of lamotrigine and oxcarbazepine combination during pregnancy.
    Wegner I; Edelbroek P; de Haan GJ; Lindhout D; Sander JW
    Epilepsia; 2010 Dec; 51(12):2500-2. PubMed ID: 21204816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quantification of oxcarbazeipine and its active metabolite 10-hydroxycarbazepine in human plasma by high-performance liquid chromatography.
    Nirogi RV; Kandikere VN; Shukla M; Mudigonda K; Ajjala DR
    Arzneimittelforschung; 2006; 56(7):517-23. PubMed ID: 16927533
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of oral loading of oxcarbazepine suspension in selected patients with epilepsy.
    Kim DW; Gu N; Lee H; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Na HJ; Lee SK
    Int J Clin Pharmacol Ther; 2013 Oct; 51(10):780-6. PubMed ID: 23849326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part II. Phenytoin, carbamazepine, sulthiame, lamotrigine, vigabatrin, oxcarbazepine and felbamate.
    Battino D; Estienne M; Avanzini G
    Clin Pharmacokinet; 1995 Nov; 29(5):341-69. PubMed ID: 8582119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of valproic acid on the pharmacokinetic profile of oxcarbazepine in the rat.
    Matar KM; Nicholls PJ; Bawazir SA; al-Hassan MI; Tekle A
    Pharm Acta Helv; 1999 Feb; 73(5):247-50. PubMed ID: 10085790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Removal of 10-hydroxycarbazepine by plasmapheresis.
    Christensen J; Balslev T; Villadsen J; Heinsvig EM; Dam M; Poulsen JH
    Ther Drug Monit; 2001 Aug; 23(4):374-9. PubMed ID: 11477319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy, tolerability, and pharmacokinetics of oxcarbazepine oral loading in patients with epilepsy.
    Kim DW; Gu N; Jang IJ; Chu K; Yu KS; Cho JY; Yoon SH; Kim HS; Oh J; Lee SK
    Epilepsia; 2012 Jan; 53(1):e9-12. PubMed ID: 22091603
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetic variability of oxcarbazepine in epileptic patients].
    Viola MS; Bercellini MA; Saidón P; Rubio MC
    Medicina (B Aires); 2000; 60(6):914-8. PubMed ID: 11436701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved detection and determination of carbamazepine and oxcarbazepine and their metabolites by high-performance liquid chromatography.
    Pienimäki P; Fuchs S; Isojärvi J; Vähäkangas K
    J Chromatogr B Biomed Appl; 1995 Nov; 673(1):97-105. PubMed ID: 8925080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetic interaction between efavirenz and carbamazepine after multiple-dose administration in healthy subjects.
    Ji P; Damle B; Xie J; Unger SE; Grasela DM; Kaul S
    J Clin Pharmacol; 2008 Aug; 48(8):948-56. PubMed ID: 18519918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.